These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Changes in and modulation of receptor activity in hepatic encephalopathy]. Kienzl E; Riederer P; Brücke T; Kleinberger G; Jellinger K Infusionsther Klin Ernahr; 1985 Feb; 12(1):32, 37-45. PubMed ID: 2859245 [TBL] [Abstract][Full Text] [Related]
8. Serum gamma-aminobutyric acid (GABA) levels in patients with hepatic encephalopathy. Minuk GY; Winder A; Burgess ED; Sarjeant EJ Hepatogastroenterology; 1985 Aug; 32(4):171-4. PubMed ID: 4054811 [TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis and diagnosis of subclinical hepatic encephalopathy]. Ciećko-Michalska I; Mach T; Słowik A Przegl Lek; 2010; 67(2):131-4. PubMed ID: 20557015 [TBL] [Abstract][Full Text] [Related]
10. Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Basile AS; Jones EA Hepatology; 1997 Jun; 25(6):1303-5. PubMed ID: 9185743 [No Abstract] [Full Text] [Related]
12. [Therapy of hepatic encephalopathy. Changes in the cerebrospinal fluid concentration of catecholamine neurotransmitters, ammonia and amino acids in the course of an infusion treatment with branched-chain amino acids]. Rössle M; Herz R; Lehmann G; Luft M; Gerok W Infusionsther Klin Ernahr; 1982 Oct; 9(5):256-8. PubMed ID: 7141673 [TBL] [Abstract][Full Text] [Related]
13. Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease. Levy LJ; Losowsky MS Hepatogastroenterology; 1989 Dec; 36(6):494-8. PubMed ID: 2613171 [TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis of hepatic encephalopathy]. Lu LG Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):304. PubMed ID: 15161512 [No Abstract] [Full Text] [Related]
15. Management of hepatic encephalopathy in patients with cirrhosis. Wright G; Jalan R Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499 [TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of cirrhotic hepatic encephalopathy. Treatment implications]. García-Compean D; Michel H Rev Gastroenterol Mex; 1995; 60(3):159-68. PubMed ID: 7481451 [TBL] [Abstract][Full Text] [Related]
17. gamma-Aminobutyric acid (GABA) and hepatic encephalopathy: testing the validity of electroencephalographic evidence of the GABA hypothesis. Myslobodsky MS Hepatogastroenterology; 1987 Apr; 34(2):58-64. PubMed ID: 3036678 [TBL] [Abstract][Full Text] [Related]
18. Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure. Michalak A; Rose C; Butterworth J; Butterworth RF Hepatology; 1996 Oct; 24(4):908-13. PubMed ID: 8855196 [TBL] [Abstract][Full Text] [Related]